22157.jpg
Global Next Generation Biological Drugs Market (2021 to 2027) - Industry Analysis, Trends, Size, and Forecasts
September 22, 2021 04:43 ET | Research and Markets
Dublin, Sept. 22, 2021 (GLOBE NEWSWIRE) -- The "Next Generation Biological Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027" report has been added to...
22157.jpg
Global Research Antibodies Market Analysis 2021-2028: Monoclonal Antibodies, Polyclonal Antibodies by Technology, Source, & Application
September 17, 2021 08:28 ET | Research and Markets
Dublin, Sept. 17, 2021 (GLOBE NEWSWIRE) -- The "Global Research Antibodies Market Analysis Report 2021-2028" report has been added to ResearchAndMarkets.com's offering. The global research...
22157.jpg
Global Immunochemicals Market Report 2021-2027 - U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 5% CAGR
September 13, 2021 05:33 ET | Research and Markets
Dublin, Sept. 13, 2021 (GLOBE NEWSWIRE) -- The "Immunochemicals - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Immunochemicals Market...
Proteintech Expands Collaboration With Epigenetics Company Active Motif
September 08, 2021 16:55 ET | Proteintech Group Inc.
ROSEMONT, Ill., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Proteintech Group, an original manufacturer of antibodies, nanobodies and recombinant proteins, today announced that it has made a strategic...
22157.jpg
Global Biopharmaceutical Market Report 2021: Market is Expected to Reach $478.08 Bn by 2026, from $330.7 Bn in 2021 - Increasing Investments in R&D
August 25, 2021 09:48 ET | Research and Markets
Dublin, Aug. 25, 2021 (GLOBE NEWSWIRE) -- The "Global Biopharmaceutical Market (2021-2026) by Product Type, Therapeutic Application, Geography, Competitive Analysis and the Impact of Covid-19 with...
Dyadic Logo Current.jpg
Dyadic and Sorrento Announce Binding Term Sheet to License Dyadic’s Lead COVID-19 Vaccine Candidate “DYAI-100” and C1 Technology for Protein-Based Coronavirus Vaccines and Therapeutics
August 11, 2021 08:35 ET | Dyadic International, Inc.
Sorrento to obtain exclusive rights in North and South America, Europe, major Asian countries (including Greater China and Japan) and certain other countries to utilize Dyadic’s C1 technology for the...
22157.jpg
Global Monoclonal Antibodies Market Report 2021-2026 - Rising Technological Advancements & Increasing Burden of Cancer and Other Chronic Diseases
August 09, 2021 05:03 ET | Research and Markets
Dublin, Aug. 09, 2021 (GLOBE NEWSWIRE) -- The "Monoclonal Antibodies Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's...
abcam-grey.png
Abcam to Acquire BioVision for $340 million
August 02, 2021 02:00 ET | Abcam
CAMBRIDGE, United Kingdom, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Abcam plc (AIM LSE: ABC; Nasdaq: ABCM) ("Abcam", “the Company” or "the Group"), a global leader in the supply of life science research...
22157.jpg
Opportunities in the Global Monoclonal Antibodies Market: CAGR of Upwards of 11% Forecast with Market Set to Reach $179.56 Billion in 2025
July 26, 2021 03:13 ET | Research and Markets
Dublin, July 26, 2021 (GLOBE NEWSWIRE) -- The "Monoclonal Antibodies (MAbS) Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's...
22157.jpg
Vectorized Antibodies for In Vivo Expression Industry - Featuring Adverum Biotechnologies, Homology Medicines and BioNTech Among Others
July 13, 2021 04:53 ET | Research and Markets
Dublin, July 13, 2021 (GLOBE NEWSWIRE) -- The "Vectorized Antibodies for In Vivo Expression by DNA and mRNA: A Landscape Analysis Of Stakeholders, Technologies, Targets, Business and Financing from...